Role of dual energy X-ray absorptiometry scan for assessing bone mineral density in patients with chronic plaque psoriasis: a cross-sectional study
Keywords:Psoriasis, Bone mineral density, Osteoporosis, Dual energy X-ray absorptiometry
Background: Psoriasis is a T cell mediated chronic inflammatory disorder of skin, joints and immune system. Data regarding possible association between psoriasis and reduced bone mineral density are limited and hence association is not fully conclusive. Systemic inflammatory cytokines in the psoriasis have been identified in the pathogenesis of reduced bone mineral density. Among various available methods, Dual X-ray absorptiometry (DXA), found to be gold standard for assessing bone mineral density.
Methods: An observation study of 30 patients with chronic plaque psoriasis aged between 18 years to 50 years fulfilling the criteria were enrolled and studied. Dual energy X-ray absorptiometry scan (DEXA) of left forearm radius (non-dominant hand) was done. T score was calculated and bone mineral density assessed based on WHO criteria. Using software SPSS version 24, Pearson’s correlation and linear regression analysis applied.
Results: Out of 30 patients, there were 18 males and 12 females. Mean age of patients 37.93 years. Majority of the psoriatic patient showed osteopenia on DEXA scan and significant positive correlation was found between duration of psoriasis disease (r=0.34, p=0.03), body surface area percentage (r=0.36, p=0.04) and body mass index (r=0.32, p=0.02).
Conclusions: Early identification of reduced bone mineral density in patients with psoriasis particularly in those with longer duration of the disease, involving large body surface area (more than 10) and with higher body mass index by DEXA scan helps to reduce osteoporotic fracture and other associated comorbidities.
Qadim HH, Goforoushan F, Nejad SB, Goldust M. Studying the calcium serum level in patients suffering from psoriasis. Pak J Biolog Sci. 2013;16(6):291-4.
Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, Beltrami G, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166(3):505-10.
Millard TP, Antoniades LA, Evans AV, Smith HR, Spector TD, Barker JNWN. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol. 2001;26(5):446-8.
D'Epiro S, Marocco C, Salvi M, Mattozzi C, Luci C, Macaluso L, et al. Psoriasis and bone mineral density:implications for long –term patients. J Dermatol. 2014;41(9):783-7.
Attia EA, Khafagy A, Abdel-Raheem S, Fathi S, Saad AA. Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol. 2011;50(1):30-5.
Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finze S, et al. Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Mineral Res. 2015;30(10):1775-83.
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595-601.
Affandi AM, Khan I, Saaya NN. Epidemiology and clinical features of adult patients with psoriasis in Malaysia: 10-year review from the Malaysian Psoriasis Registry (2007-2016). Dermatol Res Practice. 2018;2018:4371471.
Kathuria P, Gordon KB, Silverberg JI. Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures. J Am Acad Dermatol. 2017;76(6):1045-53.
Kastelan D, Kastelan M, Massari LP, Korsic M. Possible association of psoriasis and reduced bone mineral density due to increased TNF-a and IL-6 concentrations. Medical Hypotheses. 2006;67(6):1403-5.
Uluckan O, Jimenez M, Karbach S, Jeschke A, Graña O, Keller J, Busse B, et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med. 2016;8(330):330-7.
Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finzel S, Schett G. Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Mineral Res. 2015;30(10):1775-83.